ALK-rearranged lung adenocarcinoma patient with development of severe sinus bradycardia after treatment with crizotinib: A case report. [electronic resource]
Producer: 20190403Description: e14826 p. digitalISSN:- 1536-5964
- Adenocarcinoma of Lung -- metabolism
- Anaplastic Lymphoma Kinase -- antagonists & inhibitors
- Bone Neoplasms -- pathology
- Bradycardia -- chemically induced
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Crizotinib -- administration & dosage
- Dose-Response Relationship, Drug
- Female
- Humans
- Middle Aged
- Neoplasm Staging
- Pleural Neoplasms -- pathology
- Protein Kinase Inhibitors -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.